Paclitaxel Devices Safe in PAD In Medicare Data Beyond 3 Years
ATLANTA — Paclitaxel-coated devices for femoropopliteal artery revascularization were not associated with any excess mortality risk in the latest update from Medicare data. The risk of death from any cause, if anything, trended slightly lower (hazard ratio 0.98, 95% CI 0.96-0.99) with paclitaxel-eluting stents or -coated balloons compared with bare metal stent or percutaneous transluminal […]